in pictures and a few words
What it is and why it matters
Ferritin is a protein in which cells store iron safely. High ferritin is not “good reserves” but a reason to find out the cause.
- It rises when there really is a lot of iron
- But it also rises with inflammation, infections, excess weight with a disturbed metabolism, and alcohol
- A high number on its own is not yet a diagnosis
One number is not enough
Together with ferritin, doctors look at transferrin saturation — what share of the iron-carrying protein in the blood is loaded with iron. Plus tests for inflammation and for the liver.
- High saturation together with high ferritin is a reason to suspect excess iron
- With inflammation, saturation is normal or low
- A damaged liver itself releases ferritin into the blood
Where the thresholds are
The cause is looked for if ferritin is above the threshold for your group. In women before menopause the threshold is lower: periods themselves keep iron stores lower.
- Women before menopause: ferritin above 200 µg/L (same as ng/mL)
- Men and women after menopause: ferritin above 300 µg/L
- Transferrin saturation: above 45 % in women before menopause, above 50 % in men and in women after
Why excess iron is harmful
When the stores are full, free iron appears in the blood. Inside cells it produces very aggressive particles that damage them.
- The liver suffers first, then the pancreas, heart and joints
- Over time, scars form in the liver
- Today severe consequences are rare if the doctor knows what to look for
Inherited iron build-up
Haemochromatosis is an inherited disease in which the body stores excess iron. In people of Northern European descent it is one of the most common inherited diseases.
- Most people do not know they have it until the liver or heart is affected or diabetes appears
- This gene is not a sentence: not everyone builds up iron, and women do so less often
- If it is confirmed in you, brothers, sisters and children are checked; children are tested from age 18
Fatty liver is a different story
Most often ferritin is slightly raised because of fat in the liver with excess weight and a disturbed metabolism. This is not inherited iron build-up.
- Transferrin saturation is usually normal here
- Bloodletting does not treat the cause and is not indicated here
- Losing weight and putting the metabolism in order help
How iron build-up is treated
With confirmed inherited iron build-up, the main and essential treatment is bloodletting. No supplements can replace it.
- If started before liver scarring and the maintenance is kept up, life is no shorter than other people’s
- You can give blood as a donor — it is equivalent to bloodletting
- Alcohol — cut it out completely: together with iron it speeds up liver scarring
Food when there is too much iron
You can eat meat, but in moderation — giving it up completely is usually not needed. Foods with added iron are better avoided.
- Red meat 1–2 times a week; cut out liver and kidneys
- Tea, coffee or dairy with meals reduce iron absorption
- Vitamin C — not with meals and no more than 100 mg a day
Who should see a doctor first
Leave reading the tests and the decision on treatment to a doctor. Fatty liver with high ferritin — also to a doctor, to tell one from the other. Persistently high saturation with no cause — also to a doctor.
- Ferritin above the threshold for your group on repeated tests
- Saturation above 45 % in women before menopause, above 50 % in men and in women after
- Family history of haemochromatosis, cirrhosis of unclear cause, early diabetes, joint disease
Important. Ferritin above 1000 µg/L — whatever your sex and whatever the circumstances — is a reason to see a doctor straight away.
In one sentence
High ferritin is a reason to find the cause, together with transferrin saturation. Inherited excess iron is treated with bloodletting, fatty liver with weight loss.
Introduction: ferritin is not “stores,” but a signal
In routine practice, ferritin is often interpreted simplistically: low means anemia, high means “good stores.” This is a clinically dangerous oversimplification. Ferritin is an iron-storage protein and also an acute-phase reactant: it rises with inflammation, metabolic syndrome, alcohol intoxication, infections, and malignant disease. It is also an early indicator of true iron overload, which leads to liver fibrosis, cardiomyopathy, arthropathy, and insulin resistance.
The “above normal” threshold beyond which the cause must be investigated is ferritin > 200 μg/L in premenopausal women and > 300 μg/L in men and postmenopausal women — paired with transferrin saturation above 45% and 50% respectively (EASL Clinical Practice Guidelines on haemochromatosis, J Hepatol 2022, PMID 35662478). The threshold is lower in premenopausal women because menstruation itself keeps iron stores lower. This threshold does not mean a diagnosis. It means the physician has a duty to ask: why?
In parallel, in patients with MASLD (metabolic dysfunction-associated steatotic liver disease), ferritin is often mildly elevated, but this is not primary iron overload. Distinguishing these two scenarios is a clinical skill that fundamentally changes management.
🌀
What ferritin is and why it rises
The ferritin molecule is a spherical “capsule” made of 24 subunits that can hold up to 4 500 iron atoms in the form of hydroxyphosphate. This is a safe storage form: free iron is toxic, the ferritin core is not. Ferritin is intracellular, but a small fraction is secreted into plasma and measured in blood tests.
Serum ferritin rises in three main scenarios:
▸True iron overload — hereditary haemochromatosis, repeated blood transfusions, thalassemia, long-term parenteral iron. It is accompanied by increased transferrin saturation (TSAT) above 45% in premenopausal women and above 50% in men and postmenopausal women. ▸Systemic inflammation — infections, autoimmune processes, oncology, metabolic syndrome. Ferritin behaves as an acute-phase protein, while TSAT remains normal or reduced. ▸Liver injury — alcoholic hepatitis, MASLD, hepatocellular carcinoma: hepatocytes release ferritin when injured, similarly to ALT.
Therefore, isolated ferritin without TSAT, CRP, ALT, and context is clinically useless. This is the key error in laboratory interpretation.
🌀
Mechanism of iron-induced injury: the Fenton reaction
When the capacity of ferritin and transferrin is exhausted, non-transferrin-bound iron (NTBI) appears in plasma: unbound “free” iron. It enters hepatocytes, cardiomyocytes, pancreatic β-cells, and endocrine organs.
Inside the cell, Fe²⁺ reacts with hydrogen peroxide H₂O₂ through the Fenton reaction:
Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻
The hydroxyl radical (OH•) is one of the most reactive oxidants in biology. It damages membrane lipids (lipid peroxidation, LPO), proteins, and DNA. The result: lipid peroxidation, activation of hepatic stellate cells, and fibrosis formation (Pietrangelo A, Gastroenterology 2010, PMID 20542038).
Target organs in descending order of sensitivity: liver → pancreas → myocardium → joints → pituitary → gonads. Clinically, this unfolds as “bronze diabetes,” the classic triad of cirrhosis + diabetes mellitus + bronze skin pigmentation. Today the triad is rare: haemochromatosis is diagnosed before it develops if the physician knows what to look for.
🌀
Drivers of elevated ferritin
Eight causes of ferritin elevation in clinical practice, in order of frequency:
•Metabolic syndrome / MASLD — the most common cause of a “mild” ferritin elevation (300–500 μg/L) in modern practice. Mechanism: hepatocellular inflammation + moderate hepcidin block. TSAT is usually normal (below the threshold for one’s group). •Alcohol burden — even moderate consumption (>20 g/day) raises ferritin through CYP2E1 induction and oxidative stress. After 4 weeks of abstinence, ferritin falls by 30–50%. •Hereditary haemochromatosis (HFE C282Y/C282Y; C282Y/H63D only with hepatic iron overload on MRI or biopsy, EASL 2022) — C282Y homozygosity is about 1:150–250 in Northern European populations, with phenotype penetrance of 28% in men and 1% in women (Allen KJ, NEJM 2008, PMID 18199861). •Inflammation of any origin — an acute-phase response. Ferritin may be >1000 μg/L in sepsis, Still’s disease, and hemophagocytic syndrome. •Chronic transfusion burden — thalassemia, sickle cell anemia, myelodysplastic syndromes. Each unit of blood = 200 mg of iron. After 20 transfusions, the overload becomes clinically significant. •Parenteral iron in doses exceeding metabolic needs — typical in patients on hemodialysis. •Hepatocellular injury — acute and chronic hepatitis, ischemic hepatitis, drug-induced liver injury. •Malignant disease — Hodgkin lymphoma, HCC, leukemias, neuroblastomas (tumors actively use iron for proliferation).
🌀
Markers: what to order after ferritin
Isolated ferritin is not diagnostic. The minimum investigation panel for ferritin > 300 (men) or > 200 (women):
▸Transferrin saturation (TSAT) = (serum iron / TIBC) × 100%. The main marker of true overload — and at the same time a number that cannot be trusted from a single reading. TSAT > 45% in premenopausal women and > 50% in men and postmenopausal women, together with elevated ferritin, is grounds to suspect haemochromatosis. Persistently elevated unexplained TSAT is itself grounds for HFE genotyping, even with normal ferritin (EASL 2022). ▸hsCRP — to distinguish an acute-phase elevation from true overload. With inflammation and infection, ferritin ↑, while TSAT is normal or ↓. ▸ALT, AST, GGT — assessment of hepatocellular injury. In haemochromatosis, ALT is often moderately elevated without a pronounced inflammatory response. ▸HFE genotyping — what settles it is C282Y: homozygosity for it confirms the diagnosis. The indication is persistently elevated and unexplained transferrin saturation, or a family history; a single high value is not an indication. Testing for H63D is called controversial by the guideline: H63D homozygosity or the H63D/C282Y combination is associated with mild iron overload, and only with additional liver risk factors does it occasionally become clinically significant — but not to the extent seen in C282Y homozygotes. A one-time test; genetics for life. ▸Liver MRI T2* — noninvasive quantitative assessment of iron concentration (LIC, liver iron concentration). Normal <1.8 mg Fe / g dry tissue. Replaces biopsy in most patients. ▸FibroScan / ELF / FIB-4 — fibrosis assessment. With LIC > 4 mg/g and F2+ fibrosis, biopsy is indicated for precise staging. ▸HbA1c, fasting insulin — diabetes develops years before clinical overload; early screening is mandatory. ▸Echocardiography — in patients with long-standing overload to assess iron cardiomyopathy.
A detailed discussion of liver markers is in the article AST/ALT ratio and De Ritis.
Why haemochromatosis is most often missed, and who should have their iron checked even without symptoms, is covered in a separate guide.
🌀
Distinguishing haemochromatosis from MASLD-associated ferritin elevation
This distinction is critical: it determines whether phlebotomy is needed.
| Parameter | Haemochromatosis | MASLD (DIOS) |
|---|---|---|
| TSAT | > 45% (premenopausal women) / > 50% (men and postmenopausal women) | below the group threshold |
| Ferritin | 500–5000 | 300–700 |
| Treatment | phlebotomy | weight loss |
▸Primary hereditary haemochromatosis: ferritin 500–5000 μg/L, TSAT > 45% in premenopausal women, > 50% in men and postmenopausal women (often > 60–80%), HFE C282Y homozygote (compound C282Y/H63D only with hepatic iron overload on MRI or biopsy, EASL 2022), MRI T2* shows marked iron accumulation in the liver and often the myocardium/pituitary. Treatment: phlebotomy. ▸MASLD-associated ferritin elevation (DIOS — dysmetabolic iron overload syndrome): ferritin 300–700 μg/L, normal TSAT (below the threshold for one’s group), metabolic syndrome, steatosis on ultrasound or MRI-PDFF, absence of HFE mutations. Treatment: weight loss, control of insulin resistance, not first-line phlebotomy.
Prescribing phlebotomy to a patient with MASLD without an elevated TSAT (> 45% in premenopausal women, > 50% in men and postmenopausal women) is a clinical error. It does not treat the root cause (insulin resistance) and is not supported by evidence-based medicine.
🌀
Holistic protocol for iron overload
The principle of the md_pereligyn protocol: in true hereditary overload (HFE haemochromatosis with phenotype), phlebotomy is the first and mandatory line. No nutraceutical can replace it. But they can support recovery and reduce oxidative damage.
1. Phlebotomy (only with a confirmed phenotype)
▸Induction phase — 1 phlebotomy of 450–500 mL weekly or every 2 weeks until the target ferritin is < 50 μg/L. Duration ranges from 6 months to 2 years depending on baseline burden. ▸Maintenance phase — 2–4 phlebotomies per year lifelong to keep ferritin below 100 μg/L (EASL 2022). ▸Monitoring — ferritin and complete blood count before every 4th phlebotomy. ▸Alternative when phlebotomy is contraindicated (severe coronary artery disease, poor venous access): erythrocytapheresis or iron chelators (deferasirox, deferoxamine — usually for transfusional overload).
2. Dietary iron management
▸Heme iron (meat, liver) is absorbed at 15–35% regardless of stores. Limit red meat to 1–2 times per week; exclude organ meats during active overload. ▸Non-heme iron (plant-derived) is absorbed at 2–20% and regulated by hepcidin. It does not require strict restriction. ▸Tea and coffee with meals — tannins and polyphenols reduce non-heme iron absorption by 60–70%. Use as a natural chelator. ▸Calcium and dairy products with meals — reduce iron absorption by 30–50%. ▸Avoid iron-fortified foods (cereals, flour with added iron) on labels.
3. Vitamin C: critical caution
▸Vitamin C increases non-heme iron absorption 3–4-fold when taken at the same time. With iron overload, do not take vitamin C with meals and do not exceed 100 mg/day. ▸Vitamin C enhances the Fenton reaction in the presence of free iron — a potentially pro-oxidant effect. ▸After ferritin normalizes (<100 μg/L), restrictions can be relaxed.
4. Antioxidant protection
▸N-acetylcysteine (NAC) 600–1200 mg — a glutathione precursor that protects hepatocytes from oxidative stress. ▸Silymarin (milk thistle) 140 mg 3×/day — a hepatoprotector with proven antioxidant activity in liver disease. ▸Vitamin E 400 IU/day — a membrane antioxidant (discuss with a physician; use caution with coagulopathy). ▸Curcumin (with piperine) 500 mg 2×/day — binds iron into inactive complexes and has anti-inflammatory effects. ▸Green tea (3–4 cups/day) — EGCG chelates iron and reduces absorption.
5. Alcohol and liver nutrition
▸Complete abstinence from alcohol is mandatory in haemochromatosis. Alcohol + iron multiplicatively accelerate fibrosis. ▸Mediterranean / DASH pattern — olive oil, fish, vegetables, legumes, nuts. Reduces inflammation and insulin resistance. ▸Restriction of fructose and fast carbohydrates — reduces liver steatosis and systemic inflammation.
6. Family screening
▸When HFE C282Y homozygosity is confirmed in a patient, screen all siblings and children. Early detection before phenotype = life without consequences. ▸Minimum: ferritin + TSAT at age 18 in offspring of a homozygote. ▸HFE genotyping in relatives — from age 18 (ethical point: before this age, the mutation does not change management).
🌀
What does NOT work (and why)
▸“Treating high ferritin” without TSAT and context — confusing an acute-phase response with overload. Prescribing phlebotomy for MASLD-associated ferritin elevation is a common mistake. ▸Isolated iron chelators (deferasirox) for HFE haemochromatosis — not first line, more expensive, hepatotoxic, indicated only when phlebotomy is contraindicated. ▸High-dose vitamin C during active overload — increases iron absorption and the Fenton reaction. ▸“Liver cleansing” with supplements without diagnostics — time is lost before fibrosis and cirrhosis develop. ▸Ignoring family history — a missed opportunity for early diagnosis in relatives before phenotype. ▸Lactoferrin and “reducing inflammation” in true overload — do not replace phlebotomy and do not reduce tissue iron stores.
🌀
When to seek care
▸Ferritin > 200 μg/L (premenopausal women) or > 300 μg/L (men and postmenopausal women) on repeated tests ▸Ferritin > 1000 μg/L — regardless of sex and context, requires immediate investigation ▸TSAT > 45% (premenopausal women) or > 50% (men and postmenopausal women) — referral for HFE genotyping. Persistently elevated unexplained TSAT qualifies too, even with normal ferritin ▸Family history of haemochromatosis, cirrhosis of unknown etiology, early diabetes, or arthropathy ▸Northern European ancestry + unexplained fatigue, arthralgia in the metacarpophalangeal joints of the 2nd and 3rd fingers ▸MASLD + elevated ferritin — to differentiate DIOS from primary haemochromatosis
I perform the full investigation panel (ferritin, TSAT, HFE genotyping, MRI T2* when indicated, FibroScan) and create a personalized plan: phlebotomy and/or metabolic correction depending on the diagnosis.
🌀
Conclusion
Ferritin is not a marker of “enough iron”. It is an acute-phase protein and an indicator of possible overload. Interpreting it in isolation is clinically dangerous.
True hereditary haemochromatosis is one of the most common inherited disorders in Northern Europeans and, at the same time, one of the easiest to treat if caught before fibrosis. Phlebotomy is an inexpensive and fully effective intervention. The cost of missing it is cirrhosis, diabetes, cardiomyopathy, and a shorter life: in a population-based cohort, median life expectancy of C282Y homozygotes was 6.8 years lower than in matched controls (Schaefer B, Liver Int 2024).
MASLD-associated ferritin elevation is a different clinical scenario. Treatment is weight loss and metabolic correction, not bloodletting.
Distinguishing these two scenarios is the physician’s task, not the laboratory’s.
🌀
Sources
▸European Association for the Study of the Liver. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol 2022;77(2):479–502. PMID 35662478 ▸Cathcart J, Mukhopadhya A. European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis. Frontline Gastroenterol 2023;14(4):282–286. PMID 37409332 ▸Schaefer B, Pammer LM, Pfeifer B, et al. Penetrance, cancer incidence and survival in HFE haemochromatosis — a population-based cohort study. Liver Int 2024;44(3):838–847. PMID 38263707 ▸Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the AASLD. Hepatology 2011;54:328–343. PMID 21452290 — superseded by EASL 2022, cited as historical ▸Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352(17):1769–1778. PMID 15858186 ▸Adams PC, Barton JC. Haemochromatosis. Lancet 2007;370:1855–1860. PMID 18061062 ▸Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010;139:393–408. PMID 20542038 ▸Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221–230. PMID 18199861 ▸Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016;388:706–716. PMID 26975792
Related articles: Endothelium: the Foundation of Vascular Health, Cholesterol Without Statins.
🌀
FAQ
If my ferritin is high, do I need phlebotomy immediately? No. First, the cause must be established. At minimum: transferrin saturation (TSAT), hsCRP, ALT, AST, and context. Phlebotomy is indicated only in true overload (TSAT > 45% in premenopausal women / > 50% in men and postmenopausal women + elevated ferritin or confirmed HFE phenotype). In MASLD or inflammation, phlebotomy does not treat the root cause.
What should I do if the HFE genotype is C282Y homozygous but ferritin is normal? This is the pre-phenotype phase. About 72% of men and 99% of women with C282Y/C282Y will never develop clinically significant overload (the phenotype appears in 28% of men and 1% of women, Allen KJ, NEJM 2008). Management: ferritin and TSAT monitoring every 1–2 years, a diet with limited heme iron, alcohol abstinence, and screening of relatives. Phlebotomy is not needed until ferritin rises.
Can I eat meat with haemochromatosis? Yes, but in moderate amounts (1–2 times per week, portions of 80–120 g). Complete avoidance is usually unnecessary. Only organ meats (liver, kidneys) and vitamin C with meals are excluded. Tea and coffee tannins with meals reduce iron absorption.
Is blood donation effective instead of phlebotomy? Yes. With confirmed haemochromatosis, blood can be donated as a regular donor, subject to hemoglobin and interval restrictions. This is therapeutically equivalent to phlebotomy and socially useful. Many blood centers know the indication “haemochromatosis” and accept donations more frequently than standard intervals.
How long do people live with haemochromatosis? With early diagnosis (before fibrosis) and regular phlebotomy, life expectancy does not differ from the general population. In a population-based cohort, median life expectancy of C282Y homozygotes overall was 6.8 years lower than in matched controls (Schaefer B, Liver Int 2024); when diagnosed at the stage of cirrhosis or diabetes, the outlook is worse. Timeliness is the key factor.
This article is for informational purposes only and is not a substitute for professional medical advice. Discuss any nutraceutical, medication adjustment, or diagnostic procedure with your treating physician before starting.
Key facts
- Ferritin is an acute-phase reactant: it rises with inflammation, metabolic syndrome, alcohol, infections and malignancy, not only true overload.
- Investigation threshold — ferritin > 200 μg/L in premenopausal women and > 300 μg/L in men and postmenopausal women (EASL 2022).
- Transferrin saturation (TSAT) is the main marker of true overload: > 45% in premenopausal women and > 50% in men and postmenopausal women (EASL 2022).
- Free iron (NTBI) drives the Fenton reaction Fe²⁺ + H₂O₂ → OH•, injuring hepatocytes and forming fibrosis.
- Haemochromatosis (TSAT > 45% in premenopausal women, > 50% in men and postmenopausal women) needs phlebotomy; MASLD-associated elevation (TSAT below the threshold for one’s group) needs weight loss, not bloodletting.




